Matthew R. Weir, MDProfessor and Director, Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USAEdgar V. Lerma, MDClinical Professor of Medicine, Section of Nephrology, Christ Medical Center, University of Illinois at Chicago/Advocate, Oak Lawn, IL, USA

• Changes in Guideline Trends and Applications in Practice: JNC 2013 and the future.- Central BP monitoring, Home BP Monitoring, Ambulatory BP Monitoring in CKD.- Resistant hypertension in patients with chronic kidney disease.- Neurogenic Factors In Hypertension Associated With Chronic Kidney Disease.- Novel Molecules.- Dual Inhibitors: RAAS Blockers/Combination Therapies: What Do All These Trials Mean?.- Renal Sympathetic Denervation.- Novel baroreceptor activation therapy.- Blood Pressure Vaccines.- Masked Hypertension: Does it Lead to CVD or CKD?.- White Coat Hypertension- Do We Really Understand It Now?.- Uric Acid And Hypertension - Is There Really A Link?.-  Preeclampsia: Angiogenic factors, blood pressure, and the kidney.- Inflammation and Hypertension.- Genome-Wide Association Studies (Gwas) Of Blood Pressure In Different Populations.- Endocrine Hypertension and Chronic Kidney Disease.- Hypertension in Children with Chronic Kidney Disease.- Obesity/OSA/Metabolic syndrome in pts with CKD and hypertension-the missing link.

"This book reviews the etiology, pathogenesis, and treatment guidelines for patients with chronic kidney disease and hypertension. The goal is to provide a guide for all healthcare professionals, both clinical and research, in the management of hypertension, especially in the expanding population of patients with chronic kidney disease and end-stage renal disease. ... This is an excellent resource for all practitioners, educators, and students on the intricacies of hypertension and how it affects all patients." (Temitope Shodunke, Doody's Book Reviews, October, 2015)